| Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01142427) | Children's Oncology Group | 2010-08-09 |
| Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL (NCT01187810) | South Plains Oncology Consortium | 2010-08-01 |
| A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia (NCT01196013) | Genzyme, a Sanofi Company | 2010-08-01 |
| A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy (NCT01184885) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2010-07-01 |
| Veliparib and Temozolomide in Treating Patients With Acute Leukemia (NCT01139970) | National Cancer Institute (NCI) | 2010-06-04 |
| CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01134575) | M.D. Anderson Cancer Center | 2010-06-04 |
| Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL (NCT01148134) | University Health Network, Toronto | 2010-06-01 |
| Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias (NCT01149915) | Threshold Pharmaceuticals | 2010-06-01 |
| Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS (NCT01159028) | Bio-Path Holdings, Inc. | 2010-06-01 |
| HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies (NCT01119066) | Memorial Sloan Kettering Cancer Center | 2010-05-03 |
| Pharmacokinetic Study of Doxorubicin in Children With Cancer (NCT01095926) | University Hospital Muenster | 2010-05-01 |
| A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation (NCT01068301) | St. Jude Children's Research Hospital | 2010-05-01 |
| PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years (NCT01358201) | PETHEMA Foundation | 2010-05-01 |
| ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies (NCT01110473) | AbbVie (prior sponsor, Abbott) | 2010-04-01 |
| Genomic Changes in Childhood Acute Lymphoblastic Leukemia (NCT01089907) | National Taiwan University Hospital | 2010-04-01 |
| Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) (NCT01094392) | Aarhus University Hospital | 2010-03-01 |
| First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL (NCT01004497) | The Catholic University of Korea | 2010-03-01 |
| Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia (NCT01079507) | Samsung Medical Center | 2010-02-01 |
| Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 (NCT01044069) | Memorial Sloan Kettering Cancer Center | 2010-01-05 |
| Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors (NCT01014195) | St. Jude Children's Research Hospital | 2010-01-01 |
| Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia (NCT01025778) | Lund University Hospital | 2009-12-01 |
| Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic Leukemia (NCT00902213) | St. Jude Children's Research Hospital | 2009-11-01 |
| Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia (NCT01148927) | University Health Network, Toronto | 2009-11-01 |
| The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop (NCT01001390) | St. Jude Children's Research Hospital | 2009-10-01 |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation (NCT00990249) | M.D. Anderson Cancer Center | 2009-10-01 |
| A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies (NCT01036009) | University of California, San Francisco | 2009-10-01 |
| A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia (NCT00866281) | Novartis Pharmaceuticals | 2009-09-01 |
| Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00983528) | University of California, San Diego | 2009-09-01 |
| Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia (NCT00792948) | National Cancer Institute (NCI) | 2009-09-01 |
| PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia (NCT00944008) | PETHEMA Foundation | 2009-09-01 |
| A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia (NCT00964873) | Synta Pharmaceuticals Corp. | 2009-08-01 |
| T-cell Depleted Alternative Donor Transplantation (NCT00968864) | Wake Forest University Health Sciences | 2009-08-01 |
| Treatment of Older Adults With Acute Lymphoblastic Leukemia (NCT00973752) | Massachusetts General Hospital | 2009-08-01 |
| Osteonecrosis in Children With Acute Lymphoblastic Leukemia (NCT01104324) | Halton, Jacqueline, M.D. | 2009-07-01 |
| Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (NCT00940524) | Memorial Sloan Kettering Cancer Center | 2009-07-01 |
| Nilotinib Pre and Post Allogeneic Stem Cell Transplantation (NCT00750659) | Sheba Medical Center | 2009-07-01 |
| Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) (NCT01047020) | St. Jude Children's Research Hospital | 2009-06-01 |
| MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia (NCT00911066) | Millennium Pharmaceuticals, Inc. | 2009-06-01 |
| Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia (NCT00961142) | University Hospital Tuebingen | 2009-06-01 |
| Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia (NCT02544789) | Betta Pharmaceuticals Co., Ltd. | 2009-06-01 |
| Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT00905398) | Rony Schaffel | 2009-05-01 |
| Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia (NCT01523782) | ERYtech Pharma | 2009-04-01 |
| A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies (NCT00807677) | Millennium Pharmaceuticals, Inc. | 2009-03-01 |
| Sitagliptin Umbilical Cord Blood Transplant Study (NCT00862719) | Indiana University | 2009-03-01 |
| Genotyping Analysis of Acute Lymphoblastic Leukemia (NCT00961285) | University of Bologna | 2009-03-01 |
| Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) (NCT00866307) | Children's Oncology Group | 2009-02-23 |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial (NCT02872987) | Goethe University | 2009-02-01 |
| ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase (NCT00819351) | Rigshospitalet, Denmark | 2009-01-01 |
| Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) (NCT00991744) | Nordic Society for Pediatric Hematology and Oncology | 2009-01-01 |
| Second Malignant Neoplasms After Childhood ALL Therapy (NCT01476462) | Rigshospitalet, Denmark | 2009-01-01 |
| ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy (NCT00816049) | Rigshospitalet, Denmark | 2009-01-01 |
| CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene (NCT00710892) | Baylor College of Medicine | 2008-12-01 |
| Bendamustine in Acute Leukemia and MDS (NCT00790855) | M.D. Anderson Cancer Center | 2008-11-01 |
| Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer (NCT00789776) | Fred Hutchinson Cancer Center | 2008-10-13 |
| Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia (NCT00784017) | medac GmbH | 2008-10-01 |
| Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients (NCT01015261) | Tehran University of Medical Sciences | 2008-10-01 |
| CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00659425) | MedImmune LLC | 2008-09-01 |
| Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation (NCT00658411) | Dana-Farber Cancer Institute | 2008-08-01 |
| Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (NCT00671034) | Children's Oncology Group | 2008-07-21 |
| Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00720109) | National Cancer Institute (NCI) | 2008-07-14 |
| Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia (NCT07499349) | Aarhus University Hospital | 2008-07-01 |
| The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia (NCT00846703) | Sun Yat-sen University | 2008-07-01 |
| The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 (NCT04187248) | Aarhus University Hospital | 2008-07-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00723099) | Fred Hutchinson Cancer Center | 2008-06-25 |
| PACE CALL: Weight Loss Study for Childhood Leukemia Survivors (NCT01253720) | Huang, Jeannie, M.D. | 2008-06-01 |
| Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia (NCT00900445) | Children's Oncology Group | 2008-03-24 |
| Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR (NCT01611298) | Robert Krance | 2008-03-01 |
| Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00557193) | Children's Oncology Group | 2008-01-15 |
| Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia (NCT00795756) | Northern Italy Leukemia Group | 2008-01-01 |
| Aerobic and Strengthening Exercise for Acute Leukemia (NCT00766311) | St. Jude Children's Research Hospital | 2008-01-01 |
| Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) (NCT00560794) | Amgen Research (Munich) GmbH | 2008-01-01 |
| Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant (NCT00674427) | University of Pennsylvania | 2008-01-01 |
| Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia (NCT00549848) | St. Jude Children's Research Hospital | 2007-10-29 |
| The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients (NCT00726934) | Indiana University | 2007-09-01 |
| Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies (NCT00593554) | Sherif S. Farag | 2007-08-07 |
| Rapamycin in Relapsed Acute Lymphoblastic Leukemia (NCT00874562) | Dana-Farber Cancer Institute | 2007-07-01 |
| Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years) (NCT01366898) | PETHEMA Foundation | 2007-06-30 |
| Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD (NCT00539695) | Baylor College of Medicine | 2007-06-01 |
| Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) (NCT00579111) | Baylor College of Medicine | 2007-06-01 |
| Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL (NCT00529360) | New York Medical College | 2007-06-01 |
| Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. (NCT00466895) | Leslie Andritsos | 2007-04-01 |
| Natural Killer Index From Hematopoietic Stem Cell Graft (NCT00435864) | Nantes University Hospital | 2007-04-01 |
| Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation (NCT00374933) | Abramson Cancer Center at Penn Medicine | 2007-04-01 |
| ALL Adult Consortium Trial: Adult ALL Trial (NCT00476190) | Dana-Farber Cancer Institute | 2007-04-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL) (NCT00682305) | Universitätsklinikum Hamburg-Eppendorf | 2007-03-01 |
| Intraosseous Infusion of Unrelated Cord Blood Grafts (NCT00967525) | Emory University | 2007-03-01 |
| Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia (NCT03803670) | University of Rome Tor Vergata | 2007-01-01 |
| Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International (NCT00861679) | Hadassah Medical Organization | 2007-01-01 |
| Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy (NCT00606216) | Memorial Sloan Kettering Cancer Center | 2007-01-01 |
| Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL (NCT00349518) | Bristol-Myers Squibb | 2006-12-01 |
| Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults (NCT00797810) | University of Bologna | 2006-12-01 |
| Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia (NCT00678275) | Universitätsklinikum Hamburg-Eppendorf | 2006-10-01 |
| Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. (NCT00390793) | M.D. Anderson Cancer Center | 2006-09-28 |
| Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias (NCT00522990) | Astex Pharmaceuticals, Inc. | 2006-09-01 |
| Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) (NCT00440726) | Therapeutic Advances in Childhood Leukemia Consortium | 2006-08-04 |
| Rituximab Combined With Chemotherapy in Burkitt's Lymphoma (NCT00388193) | PETHEMA Foundation | 2006-08-01 |
| Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies (NCT00460694) | Singapore General Hospital | 2006-08-01 |
| A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL (NCT00774332) | Cooperative Study Group A for Hematology | 2006-06-01 |
| Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma (NCT00693602) | St. Jude Children's Research Hospital | 2006-06-01 |